AJMC: How have the concept of managed care and the conversations around it changed over the past 30 years? CHERNEW: Thirty years ago, managed care was new, and all of the related activities to ...
Removing community-based mental health and addiction services from New York's Medicaid managed-care program will save the ...
INTRODUCTION In American healthcare, Medicaid presents significant challenges, particularly regarding inpatient stay approvals. In recent years, Medicare and the Two-Midnight Rule have dominated ...
Industry-wide pressures are necessitating that home-based care providers step away from traditional fee-for-service models – ...
Managed care strategies employed by insurance plans should have the goal of improving health outcomes for patients rather ...
Medicaid managed care may have reached a “tipping point” in 2014, with the number of managed care beneficiaries swelling while fee-for-service enrollment actually dropped, according to a recently ...
To mark the 30th anniversary of The American Journal of Managed Care, each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the ...
Medicaid long-term care is rapidly changing, and some of those trends may eventually remake the way all of us receive personal assistance as we age or become disabled. Nearly half of all states are ...
Managed care contracting is a tricky art in today’s healthcare environment, and perhaps even more so for surgical hospitals. Naya Kehayes, managing principal and CEO of Eveia Health Consulting and ...
Health care spending in 2019 reached $3.8 trillion, 17.7 percent of the gross domestic product in the United States. Likewise, employer-sponsored health insurance premiums — which cover about 157 ...
With the announcement of the nursing home minimum staffing rule, I asked myself the same question as operators nationwide: how on earth are we going to pay for this? Even if nursing homes could find ...
Pharma firms have begun partnering with managed care companies to find real-world drug evidence and improve outcomes. But can this strategy provide the proof payers demand before giving products ...